Tower Research Capital LLC (Trc) Comera Life Sciences Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.29 - $0.68 $6 - $16	-24 Reduced 0.33%	7,338 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.4 - $0.89 $718 - $1,598	1,796 Added 32.27%	7,362 $3,000
Q1 2023 May 09, 2023	BUY	$0.84 - $1.9 $3,588 - $8,116	4,272 Added 330.14%	5,566 $5,000
Q4 2022 Feb 10, 2023	SELL	$1.2 - $1.93 $1,908 - $3,068	-1,590 Reduced 55.13%	1,294 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.09 - $4.01 $3,201 - $142,635	-35,570 Reduced 92.5%	2,884 $5,000
Q2 2022 Aug 15, 2022	BUY	$1.17 - $14.25 $44,991 - $547,969	38,454 New	38,454 $102,000

Ticker CMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,087,200
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.